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Abstract
Proper control of Epidermal Growth Factor Receptor (EGFR) signaling is critical for normal development and regulated cell
behaviors. Abnormal EGFR signaling is associated with tumorigenic process of various cancers. Complicated feedback
networks control EGFR signaling through ligand production, and internalization-mediated destruction of ligand-receptor
complexes. Previously, we found that two isoforms of D-Cbl, D-CblS and D-CblL, regulate EGFR signaling through distinct
mechanisms. While D-CblL plays a crucial role in dose-dependent down-regulation of EGFR signaling, D-CblS acts in normal
restriction of EGFR signaling and does not display dosage effect. Here, we determined the underlying molecular mechanism,
and found that Drk facilitates the dose-dependent regulation of EGFR signaling through binding to the proline-rich motif of
D-CblL, PR. Furthermore, the RING finger domain of D-CblL is essential for promoting endocytosis of the ligand-receptor
complex. Interestingly, a fusion protein of the two essential domains of D-CblL, RING- PR, is sufficient to down-regulate
EGFR signal in a dose-dependent manner by promoting internalization of the ligand, Gurken. Besides, RING-SH2
Drk, a fusion
protein of the RING finger domain of D-Cbl and the SH2 domain of Drk, also effectively down-regulates EGFR signaling in
Drosophila follicle cells, and suppresses the effects of constitutively activated EGFR. The RING-SH2
Drk suppresses EGFR
signaling by promoting the endosomal trafficking of ligand-receptor complexes, suggesting that Drk plays a negative role in
EGFR signaling by enhancing receptor endocytosis through cooperating with the RING domain of D-Cbl. Interfering the
recruitment of signal transducer, Drk, to the receptor by the RING-SH2
Drk might further reduces EGFR signaling. The fusion
proteins we developed may provide alternative strategies for therapy of cancers caused by hyper-activation of EGFR
signaling.
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Introduction
Ubiquitination occurs via sequential activation and conjugation
of ubiquitin to target proteins by ubiquitin activating enzyme (E1),
ubiquitin-conjugating enzyme (E2) and ubiquitin ligase (E3) [1].
Aside from protein degradation, ubiquitination represents a
crucial signal for the endocytosis of signaling molecules such as
EGFR. The attenuation of EGFR signaling by endocytosis serves
to properly control cell growth, differentiation, and normal
developmental processes [2,3,4,5]. Consistent with an intimate
role in signaling regulation, as well as in other cellular processes,
emerging evidence has shown that derailed endocytosis disrupts
developmental processes and leads to cancer formation [6,7].
A critical E3 ubiqutin ligase mediating the ubiquitiation-
dependent receptor endocytosis is the proto-oncogene Casitas B-
lineage lymphoma (Cbl), which was first identified as the cellular
homolog of v-cbl, which induces pre-B-cell lymphomas and
myeloid tumors [8,9]. Cbl is involved in multiple signaling
pathways, and plays a negative role in EGFR signaling that is
conserved among many species [10]. In Drosophila, D-Cbl
negatively regulates EGFR signaling in dorsoventral patterning
during oogenesis [11], in eye development [12,13,14], and in
border cell migration [15]. The Cbl recognizes receptor tyrosine
kinase (RTK, such as EGFR) and non-receptor tyrosine kinases
through a phosphotyrosine-binding (PTB) domain [10,16].
Internalizing EGFR requires c-Cbl and Lys63-linked polyubiqui-
tin chain modification mediated by c-Cbl is essential for sorting
activated receptors to the lysosomal degradation compartment
[17,18,19]. The RING finger domain in Cbl is highly conserved
during evolution, particularly for critical amino acids related to E3
ligase activity [16,20]. The C-terminal proline-rich (PR) domain
for protein-protein interaction and the ubiquitin association (UBA)
domain are found only in some members of the family [21]. In
Drosophila, two major isoforms, D-CblL and D-CblS are generated
from the single D-Cbl gene [22]; the shorter isoform D-CblS lacks
the proline-rich and UBA domains.
Studies in mammals have shown that the endocytosis of EGFR
involves multiple pathways, depending on EGF concentration and
exhibits cell-based specificities [2,23,24]. Therefore, redundancy
of multiple pathway of endocytosis made it difficult to dissect
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patterning has served as a sensitive and simple system to read out
the levels of EGFR signaling levels [25,26], thus representing an
ideal model of mechanistic studies. The advantage of this in vivo
system is that it provides physiological conditions with a gradient
of ligand concentration to induce different levels of EGFR
activation that is reflecting through the D/V patterning of eggshell
and embryo. The Gurken, a TGF-a homolog, is produced by the
oocyte and activates EGFR in follicle cells to specify the dorsal cell
fates, followed by attenuation of EGFR signaling via negative
regulators, such as sprouty, and kekkon, which together determine
the area of the follicle epithelium where the dorsal appendages
(DAs) form [27,28]. Importantly, examining the Gurken distribu-
tion in loss of D-Cbl and D-CblL over-expression conditions has
revealed that D-CblL promotes endocytosis of ligand-receptor to
control the amount of available ligand. We demonstrated that D-
CblL facilitates the activated receptor to traffic through the
endocytic pathway for terminating signaling at lysosomal degra-
dation compartment [29]. Therefore, over-expression of D-CblL
at different levels resulted in different degrees of ventralization,
corresponding to phenotypes resulting from different severities of
gurken mutant alleles [30]. This dose-dependent, negative effect on
EGFR signaling is specific to D-CblL and is not produced by over-
expression of D-CblS.
To understand how D-CblL controls EGFR signaling at the
molecular level, this study investigates which molecular interaction
with D-CblL is sufficient to facilitate the endocytosis of the ligand-
EGFR complex in Drosophila egg chambers. This work first
demonstrates that the factor Downstream of receptor kinase (Drk)
plays a major role in D-CblL mediated down-regulation of EGFR
signaling in a dose-dependent fashion. In addition, E3 ligase
activity is required for D-CblL activity, because over-expression of
D70Z-D-CblL, an E3 defective mutant, blocked ligand-receptor
internalization and produced a dominant-negative effect. We
generated the RING-SH2
Drk chimeric protein, containing two
functional domains of D-Cbl and Drk, and found that this
chimeric protein not only attenuated EGFR signaling, but also
down-regulated constitutively activated EGFR, l-top. We further
demonstrated that RING-SH2
Drk suppresses EGFR signaling by
enhancing the endosomal trafficking of the ligand-receptor
complex and interfering with the recruitment of the endogenous
Drk.
Results
Drk plays a major role in D-CblL mediated down-
regulation of EGFR signaling
In this study, we set out to elucidate the molecular mechanism
by which D-CblL promotes the endocytosis of the ligand-receptor
complex. Since this effect of D-CblL was not observed for D-CblS
even when expressed at a similar level [30], we suspected that D-
CblL may mediate the internalization by its extra C-terminus that
is distinct from D-CblS. In mammals, Grb2 (Growth factor
receptor binding protein 2), Eps15 and the CIN85-Endophilin
complex are involved in Cbl-mediated down-regulation of EGFR
signaling [31,32,33]. We then tested for their involvement in D-
CblL mediated down-regulation of EGFR signaling in Drosophila
oogenesis by a sensitive genetic assay. While Drosophila Eps15,
endophilin A and endophilin B had no or minor effects (Table S1), the
Drosophila Grb2 homolog drk exhibits a strong link to D-CblL
activity described below.
Mammalian studies demonstrated that c-Cbl is recruited to
EGFR through directly binding the Y1045 residue of EGFR or
indirectly interacting with Grb2 [34,35,36,37]. The Tyr1068/
1086 of EGFR is the direct docking site for the SH2 domain of
Grb2 [38]. The SH3 domain of Grb2 binds to the proline-rich
region of D-CblL, which is absent in D-CblS. We used the drk
EOA
mutant, which loses binding to EGFR caused by mutation in the
SH2 domain [39], for a genetic interaction assay. The ventralized
effect by EQ1-Gal4-driven over-expression of D-CblL in the follicle
cells was significantly reduced in the heterozygous drk
EOA mutant
background (Table 1 and Figure 1A–D). EQ1-Gal4 is mainly
expressed in the follicle cells [30]. We reasoned that if Drk was
required for the effect of D-CblL over-expression, the interruption
of interaction between Drk and D-CblL would block the D-CblL
over-expression effects. To address this issue, we found one
consensus sequence PPLPPR of the Grb2/Drk binding motif on
D-CblL (named PR), and generated a mutant in this motif by
replacing the first and fifth prolines with alanines (mPR)
(Figure 1E). The results from the yeast two hybrid system showed
that the wild-type PR, but not the mPR, interacted with full-length
Drk (Figure S2). Consistently, in the anti-D-Cbl immunoprecip-
itation assay, much less Drk was pulled down in the D-CblL-mPR
complex than in the wild-type D-CblL complex, even though D-
CblL-mPR was expressed at a higher level compared to that of D-
CblL (Figure 1F). We then over-expressed D-CblL-mPR or D-
CblL in follicle cells using EQ1-Gal4. At comparable levels (Figure
S1A), the over-expression effects of D-CblL-mPR on EGFR
signaling were much weaker than that of D-CblL. Furthermore,
the effect of D-CblL-mPR over-expression was not suppressed in
the heterozygous drk
EOA mutant background, suggesting that PR of
D-CblL might be a critical binding domain for Drk (Table 1).
We further analyzed the function of the D-CblL-mPR mutant
using a constitutive expression promoter, HS83 [40], which was
also used in rescue assays by D-CblL and D-CblS. Two transgenic
lines, hs83-D-cblL-mPR-7 and hs83-D-cblL-mPR-4, rescued the
lethality of the cbl
F165 null mutant and 75%,80% of the expected
animals developed to adults (Table 2). The rescue ability of the D-
CblL-mPR mutant was comparable to that of D-CblS (90,100%).
Moreover, unlike the wild-type D-CblL, cbl mutant flies rescued by
Table 1. The genetic interaction between D-CblL and Drk
depends on the PR
638-643 motif of D-CblL.








EOA/+ 00 39 7 4 2 1
L-A10 14 03 8 2 1 2 9 4
L-A10 in drk
EOA/+ 02 95 6 1 5 2 4 7
L-A12 5.2 66.2 26.3 2.3 311
L-A12 in drk
EOA/+ 02 76 3 1 0 1 7 6
mPR-AE 0 0 25 75 212
mPR-AE in drk
EOA/+ 0 0 25 75 390
mPR-GB 04 74 9 42 5 0
mPR-GB in drk
EOA/+ 05 05 0 03 6 2
*The number shows percentage in each phenotype.
¥The Egfr activity is correlated with morphology of dorsal appendage, two
dorsal appendages indicate normal activity of Egfr (Wt), two dorsal
appendages fused at the base indicate low level of Egfr activity (V1), one fused
dorsal appendage indicates the lower level of Egfr activity (V2), and no
appendage indicates the lowest level of Egfr activity (V3).
#EQ1-Gal4-driven over-expression of each D-CblL or D-CblL-mPR transgenic line
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laid (data not shown), although the expression level of hs83-D-cblL-
mPR was similar to that of hs83-D-cblL (Figure S1B). These data
indicate that the interaction between D-CblL and Drk underlies
the functional difference between the D-CblS and D-CblL, and
provide the basis for the dose-dependent, negative effects of D-
CblL on EGFR signaling. However, this interaction is not essential
for D-CblL function in terms of the normal restriction of EGFR
signaling.
The E3 ligase activity of D-CblL is essential for its negative
role in EGFR signaling
A screen for D-Cbl loss-of-function alleles has identified
mutations in the RING domain [13]. Indeed, mouse fibroblasts
that express D70Z-Cbl, an E3 defective mutant with a deletion of
17 amino acids prior to the RING finger domain, show increased
EGFR activation upon ligand stimulation [41,42]. In addition, the
D-v-cbl and D-cblS-onco (D-CblS-D70Z) act as dominant negative
mutants in the Drosophila eye and wing, which is presumably
resulted from competing with wild-type D-Cbl for binding to the
EGFR [43]. However, one proposed inhibitory function of Cbl in
EGFR signaling is acting as an competitor with Sos (Son of
sevenless) by binding to Grb2, thereby blocking signaling through
the Ras-MAPK pathway [21]. We decided to test whether the E3
activity is essential for D-CblL function in the dose-dependent
EGFR regulation. First we tested the involvement of ubiquitina-
tion in D-CblL-mediated regulation using the E2-conjugase
mutant, eff
8, which has been shown to be involved in D-v-cbl
function [43,44,45]. The effect of D-CblL over-expression was
reduced in the eff
8 heterozygous mutant (Table S2), indicating the
attribution of ubiquitination in D-CblL effects. A deletion mutant
similar to D-CblS-D70Z, which should be E3 defective, was
generated for D-CblL, and notably dominant negative effects on
EGFR signaling were observed upon its over-expression in the
wing, eye and follicle cells (Figure 2). Significantly, the dominant
effect of D-CblL-D70Z could be suppressed in drk
EOA heterozygous
mutant background (Figure 2I), indicating that the interaction
between Drk and D-CblL is required for the dose-dependent effect
Figure 1. D-CblL directly interacts with Drk through its PR motif. (A and A9) The EGFR activity is correlated with the morphology of dorsal
appendages. Two dorsal appendages indicate normal activity of EGFR (wt). (B and B9) Two dorsal appendages fused at the base indicate low level of
EGFR activity (V1), whereas (C and C9) one fused dorsal appendage indicates a even lower level of EGFR activity (V2). (D and D9) No appendage
indicates the lowest level of EGFR activity (V3). (E) The schematic structure shows the wild-type D-CblL, which contains the TKB domain in its N-
terminus (red), the RING finger domain (yellow) and the proline-rich domain in the C-terminus. The predicated binding motif of Drk on D-CblL is
PPLPPR (shown in purple). The first and fifth prolines of the PR motif on D-CblL-mPR mutant were replaced by alanines (shown in Box). (F) The D-CblL
was immunoprecipitated from OreR (wild-type) or two hs83-D-cblL-mPR; cbl
F165 rescued fly lines (line 4 and line 7) by the anti-D-CblL antibody (rE6).
The immunoprecipitates (IP-10 ml out of 30 ml) were separated by the SDS-PAGE, and detected by the anti-D-CblL antibody (8C4) and the anti-Drk
antibody. Supernatants (Sup.) were produced after immunoprecipitating, indicating the ability of immunoprecipitation in this experiment. 30 ml out
of 400 ml total lysate was analyzed by western blotting in each lane. The Drk signal is near 24KD (arrow).
doi:10.1371/journal.pone.0017097.g001
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D70Z could not rescue the cbl
F165 null mutant (data not shown),
reinforcing the dependence of the negative role of D-CblL in
EGFR signaling depends on the E3 activity.
We had previously shown that there is an increase of the endocytic
Gurken (HRP-Gurken) in follicle cells after D-CblL over-expression,
implying that D-CblL promotes the endocytosis of the Gurken-
EGFR complex [29]. To clarify the requirement of ubiquitination in
D-CblL-mediated ligand-receptor endocytosis, the distribution of
HRP-Gurken in follicle cells was examined. The HRP-Gurken signal
was abolished in follicle cells with D-CblL-D70Z over-expression
(Figure 3C, C9 and C0), whereas the signal was clearly detected in
wildtypeorD-CblLexpressingfolliclecells(Figure3AandB).Taken
together, our results showed that the E3 activity of D-CblL plays an
essential role in promoting ligand-receptor endocytosis.
The D-CblL fusion proteins down-regulate EGFR signaling
Based on the functional implications of the D-CblL’s interaction
with Drk and E3 ligase activity, we therefore aimed to test next
whether these two functional domains are sufficient to effectively
down-regulate EGFR. A fusion protein containing the RING
finger domain and the PR motif of D-CblL was generated (Figure 4
A). We expected that the fusion protein could interact with EGFR
through binding to Drk. In line with this notion, we also generated
a chimeric protein that contained the RING finger domain of D-
CblL and the SH2 domain of Drk (Figure 4 A). This RING-
SH2
Drk chimera should be able to bind to the activated EGFR on
pY1068 or pY1086 that can be recognized by the SH2 domain of
Drk.
To test the effects of these fusion proteins on EGFR signaling,
ectopic expression of UAS-Flag-RING-SH2
Drk and of UAS-
RING-PR were induced in follicle cells by GR1-Gal4 at 29uC and
32uC, respectively (Figure S1). At 25uC, only low levels of D-Cbl
fusion proteins were expressed, resulting in a slight defect on the
eggshell morphology (data not shown). High-level expression of
RING-SH2
Drk at 29uC resulted in significantly reduced EGFR
signaling, and about half of the eggshells showed an intermediate
ventralization phenotype indicated by the fusion of two dorsal
appendages (Table 3 and Figure 1C). The effects were correlated
with expression levels of the fusion protein (Figure S1). Even
though expression of RING-PR had a weaker effect than that
caused by expression of RING-SH2
Drk, high level expression of
RING-PR, induced by hsGal4 (Figure S1D), also effectively down-
regulated EGFR signaling and caused about 1/3 of the eggshells to
display the intermediate ventralization phenotype (Table 3,
Figure 1C). Consistent with our previous observations [29],
Gurken distribution outside of the follicle cells was also reduced
when RING-SH2
Drk or RING-PR were over-expressed in follicle
cells, similar to the effects caused by D-CblL over-expression
(Figure 4). These results showed that these small fusion proteins, as
well as full length D-CblL, could down-regulate EGFR signaling in
a dose-dependent manner. Furthermore, RING-SH2
Drk and
RING-PR can promote the internalization of ligand-receptor
complexes and lead to a reduction of extracellular Gurken
distribution.
RING-SH2
Drk down-regulates EGFR signaling through
endosomal sorting and competition with Drk
We previously demonstrated that D-CblL promotes the
internalization of the Grk/EGFR complex via the Rab5/Rab7
endocytic pathway [29]. To determine the route in endosomal
trafficking of RING-SH2
Drk-mediated endocytosis, we assayed the
HRP-Grk/EGFR complex using the anti-HRP antibody in follicle
cells expressing the RING-SH2
Drk chimera protein. More HRP-
Grk signals were co-localized with Rab5-GFP and Rab7-GFP in
follicle cells expressing either D-CblL (Figure 5E, E9,F ,K ,K 9 and
L) or RING-SH2
Drk (Figure 5 C, C9,D ,I ,I 9 and J), compared to
those observed in wild-type cells (Figure 5A, A9,B ,G ,G 9 and H).
The frequencies of detecting co-localization signals of HRP-Grk
and Rab5-GFP/Rab7-GFP were 17%/15% (n=14/n=12 egg
chambers) in wild-type, 35%/26% (n=8/n=22) and 38%/23%
(n=16/n=14) in cells expressing D-CblL and RING-SH2
Drk,
respectively. Furthermore, the signals of exogenous D-CblL or
RING-SH2
Drk proteins detected by anti-Flag antibody were
trapped near the cell cortex in follicle cells expressing dominant
negative Rab5S43N (data not shown). We then further examined
the multivesicular body (MVB) sorting of D-CblL- and RING-
SH2
Drk-mediated trafficking using the anti-Hrs antibody that
labels sorting endosomes. 22% (n=12) and 29% (n=11) of HRP-
Grk signals were co-colocalized with Hrs signal in follicle cells
respectively expressing D-CblL (Figure 5 Q, Q9 and R) or RING-
SH2
Drk (Figure 5 O, O9 and P), whereas only 16% (n=12) HRP-
Grk/Hrs co-localization signal were observed in wild-type egg
chambers (Figure 5 M, M9 and N). This observation suggests that
RING-SH2
Drk-mediated endocytosis shares the same trafficking
route with D-CblL through the early endosome, late endosome
and MVB to lysosome, and all steps of endocytosis are increased in
the D-CblL or RING-SH2
Drk expressing cells.
Because the SH2 domain of RING-SH2
Drk was derived from
Drk, we assumed that the docking site for RING-SH2
Drk on
EGFR is the same as that for Drk. Therefore, this chimeric protein
might compete with endogenous Drk for binding to EGFR. This
possibility was tested by immunoprecipitation using anti-EGFR
antibodies to determine the amount of Drk in the receptor
complex. 40% of Drk in the EGFR complex was reduced in egg
chambers expressing RING-SH2
Drk or full length D-CblL,
compared to the wild-type egg chambers (Figure 6). This result
indicates that RING-SH2
Drk interferes with the interaction
between endogenous Drk and EGFR, which may lead to reduced
signal transduction. Taken together, the chimeric protein RING-
SH2
Drk may down-regulate EGFR signaling through promoting
the endosomal trafficking of the EGFR complex and reducing the
recruitment of Drk/Sos in signal transduction.
Discussion
To dissect the molecular machinery for EGFR endocytosis, we
studied the mechanism by which D-CblL promotes EGFR










(%) V2* (%) N
S-2 100 90 0 368
L-6 0 12 97 66
L-mPR-7 80 n.d
¥ 07 1 2
L-mPR-4
1 - 75 0 443
"Each transgenic line was tested at 25uC.
*V2 phenotype indicated V2 phenotype, which is one fused dorsal appendage.
¥n.d.: non-detected
1This transgenic line is homozygous lethal.
doi:10.1371/journal.pone.0017097.t002
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PLoS ONE | www.plosone.org 4 February 2011 | Volume 6 | Issue 2 | e17097Figure 2. Dominant negative effects of D-CblL-D70Z. (A) This picture is a dorsal view of the wild-type eggshell. The dorsal midline is the region
between the two dorsal appendages (indicated by yellow arrow). (B) Expression of D-CblL-D70Z in follicle cells driven by EQ1-Gal4 resulted in a dorsalized
eggshell characterized by an expanded dorsal midline (yellow arrow). (C) In the wild-type embryo, the eight ventral denticle belts represent the ventral
structure. (D) Expression of D-CblL-D70Z in the follicle cells driven by GR1-Gal4 resulted in a dorsalized embryo that lost the anterior ventral structure.
(E) Wild-type adult eye. (F) Ubiquitous expression of D-CblL-D7 0 Zi ne y e sd r i v e nb yGMR-Gal4 generated a rough eye phenotype. (G) Wild-type adult wing.
(H) Expression of D-CblL-D70Z in the wing by MS1096-Gal4 caused an extra vein phenotype. (I) The effect of UAS-D-cblL-D70Z expression could be
suppressed in drk
EOA/+ background. The percentage of the wild-type and dorsalized eggshell are indicated in the blue and red column, respectively.
doi:10.1371/journal.pone.0017097.g002
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to generate a chimeric protein, containing the RING finger
domain of Cbl fused to the SH2 domain of Drk, which can very
effectively down-regulate EGFR signaling.
Drk plays two roles in EGFR signaling in Drosophila
oogenesis
Mammalian studies have reported that c-Cbl regulates EGFR
signaling through its interacting molecules, such as Grb2, CIN85-
Endophilin complex and Eps15 [21]. This study investigated the
role of these molecules in D-CblL mediated regulation, and found
that elimination of Drk interaction resulted in significant reduction
of the effect of D-CblL over-expression (Table 1). In consideration
of our data and results from previous studies, we conclude that the
Grb2/Drk has dual roles in EGFR signaling both in mammals and
Drosophila. Acting as a signaling transducer, Grb2 binds to the
proline rich motif of RasGEF/Sos through the SH3 domain,
leading to Ras activation and activation of MAPK cascade [46].
Similarly, loss of function of a drk mutant in Drosophila caused a
ventralization of the egg, a phenotype representing hypo-
activation of EGFR signaling [47]. In contrast, a recombinant
SH2 domain of Grb2 inhibited EGFR endocytosis, indicating the
requirement of Grb2 in EGFR endocytosis [48]. Here, we
demonstrated that interaction between D-CblL and Drk is crucial
for promoting EGFR endocytosis by D-CblL. Our protein
interaction data in this study (Figure 1F and Figure S2) agree
with previous finding that Drk/Grb2 interacts with the proline-
rich motif of Cbl [49,50]. In cell culture studies, the indirect
binding of EGFR to Cbl through Grb2 is necessary for receptor
internalization, whereas endosomal sorting requires direct binding
to Cbl [31,35]. Our findings showed that the chimeric protein is
sufficient to down-regulate EGFR signaling and suppresses the
effect of l-top over-expression in Drosophila ovaries (Table 3 and 4).
Expression of RING-SH2
Drk facilitated the endosomal trafficking
of ligand-receptor complex through Rab5 (early) and Rab7 (late)
endosomes, and MVBs (Figure 5). This result argues that
recruiting the RING domain of Cbl to EGFR by the SH2 domain
of Drk can promote the trafficking of EGFR to degradation
compartments, such as MVBs. Furthermore, expression of RING-
SH2
Drk led to reduced Drk binding on EGFR (Figure 6). This
observation suggests that RING-SH2
Drk chimeric protein not only
promotes the trafficking of EGFR to lysosomal degradation
pathway, but also competes away the endogenous Drk, which
may also contribute to reducing EGFR signaling. Interestingly,
over-expression of D-CblL also reduced the binding of Drk to
EGFR, suggesting that D-CblL might sequester Drk from binding
to the receptor for signaling.
Importantly, the lethal effect of D-CblL was significantly
reduced when the Drk binding motif was mutated in D-CblL
(Table 2). This indicates that D-CblL efficiently down-regulates
EGFR signaling through Drk. Large amounts of D-CblL in the
cell may lead to comprised EGFR signaling levels that are too low
for survival. However, even when we eliminated the interaction
with Drk in the D-CblL-mPR mutant, this protein could still
down-regulate l-top (Table S3). This result further demonstrated
that D-CblL down-regulates EGFR through multiple mechanisms,
and other D-CblL interacting molecules besides Drk might play
important roles in down-regulating EGFR signaling even when
Drk is absent.
The role of the RING finger domain in Cbl-mediated
down-regulation of EGFR signaling
Our previous study demonstrated that D-cbl is required for
down-regulation of EGFR signaling during DV patterning of the
eggshell and embryo. Here we further showed that the RING
finger domain of D-CblL is essential for its negative effect on
EGFR, since the D-CblL mutant protein lacking this domain
(D70Z-D-CblL) exhibited a dominant negative effect (Figure 2). In
addition, the D70Z-D-CblL mutant also failed to rescue cbl
F165
mutant, indicating that RING finger domain activity plays a major
role in D-CblL function. These data are consistent with results
from studies on the D-Cbl loss-of-function alleles by Wang et al.
[13] and from research reports in mammals [42,51,52]. Ubiqui-
tination has been considered as a signal to mediate EGFR
Figure 3. Expression of the D-CblL-D70Z mutant reduces endocytosis of Grk-receptor in follicle cells. (A and A9) The HRP signals
represented the ligand-receptor complex in the follicle cell (green), and were detected in the dorsal-anterior corner of the middle stage egg
chambers (arrowhead). (B, B9 and B0) Over-expression of D-CblL (red) promoted endocytosis of the ligand-receptor in follicle cells (arrows). (C, C9 and
C0) However, expression of D-CblL-D70Z (red) significantly reduced HRP-Grk signals in the follicle cells. (B9 and C9) The D-CblL or D-CblL-D70Z
expression are shown in B9 and C9, respectively. The composite image of several confocal sections of an egg chamber with HRP-Grk. Scale bars:
20 mm.
doi:10.1371/journal.pone.0017097.g003
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endosormal sorting [17,31,35,53,54]. D-CblL promotes EGFR
endocytosis in a dose-dependent manner, but the endocytosis of
the ligand-receptor complex was significantly reduced in D70Z-D-
CblL over-expressing follicle cells. Interestingly, a cell culture
system that expressed an EGFR mutant with a reduced
ubiquitination level (to only 1%) still displayed normal internal-
ization [53]. Therefore, one possibility is that the endocytic signal
is not ubiquitination of EGFR itself [53], and that other molecules
might be involved and ubiquitinated by Cbl. Cbl can directly bind
Figure 4. The RING domain fusion protein alteres the Grk distribution. (A) The schematic structure shows the constructions of E3 fusion
proteins. RING-SH2
Drk, the RING finger domain of D-CblL (red orthogon) fused with the SH2 domain of Drk (yellow orthogon). RING-PR, the RING
finger domain was fused with PR motif (amino acid 638 to 643; PPLPPR; gray orthogon). RING was composed with the RING finger domain and the
linker (blue orthogon) of D-CblL. The RING, RING-PR and RING-SH2
Drk were in-frame fused with a Flag-tag (red circle). (B-F) Gurken is asymmetrically
expressed (green) in the dorsal-anterior corner of the middle-stage wild-type egg chamber (B). The normal Gurken expression pattern spreads about
8 to 10 follicle cells (indicated by white line in B). Expression of D-CblL (C), RING-PR (E), or RING-SH2
Drk (F) led to a reduced Grk distribution (white lines
shown in C, E, F), but no significant effect was observed in the egg chamber expressing RING (D). (G) Quantitative data of B, C, D, E, and F, and the
percentages indicated middle stage egg chambers with a normal pattern (*p,0.05; ** p,0.001).
doi:10.1371/journal.pone.0017097.g004
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the binding-deficient Y1045F EGFR mutant is internalized almost
as efficiently as the wild-type EGFR, indicating that direct binding
of Cbl to EGFR is not necessary for EGFR endocytosis [55].
Indeed, the chimeric protein (RING-SH2
Drk) we generated
promoted ligand-receptors endocytosis as well (Figure 4 and
Figure 5). Therefore, we conclude that direct interaction between
Cbl and EGFR may not be necessary for ligand-receptor
endocytosis in vertebrate and invertebrate cells. Considering that
Cbl acts as an adaptor in many signaling pathways [21], we were
surprised to find that the RING finger domain, while recruited
specifically to EGFR, is sufficient to down-regulate EGFR
signaling. This finding implies the possibility of using the RING
finger domain as a therapeutic tool in human diseases treatment.
Materials and Methods
Fly strains






research); UAS-CblL-A9; UAS-CblL-A10; UAS-CblL-A12; UAS-CblL-
A18; Hs83-CblL-6 and Hs83-CblS-2 [30]; EQ1 and GR1 Gal4 lines
[57]; cbl
F165/TM3 [11]; UAS-l-top [57]; UAS-GFP-Rab5 [58]; UAS-
GFP-Rab7 [59]; HRP-grk-5 [29].
Table 3. RING-PR and RING-SH2
Drk down-regulate Egfr
signaling in a dose dependent manner.
% Eggshell phenotype
Genotypes V3 V2 V1 Wt N
At 256C
flag-D-CblL-1 18 80 1 1 364
flag-D-CblL-6 49 33 0 2 4 3
At 296C( 3 2 6C)
RING-A
" 0 (0) 0 (3) 1 (12) 99 (85) 271 (367)
RING-B
" 0 (0) 0 (5) 0(6) 100 (89) 233 (333)
RING-B2; RING-B
¥ 01 3 9 6 1 4 8
RING-SH2
Drk-2
" 0 (0) 2 (40) 26 (48) 72 (12) 334 (503)
RING-SH2
Drk-5
" 0 (0) 19 (58) 24 (36) 57 (6) 376 (430)
RING-PR-A
" 0 (0) 8 (2) 25 (22) 67 (76) 220 (374)
RING-PR-D
" 0 (0) 0 (0) 12 (7) 88 (93) 154 (164)
RING-PR-A; RING-PR-D
¥ 03 42 3 4 3 2 5 3
1The egg collection was done at 25uC, and expressions were driven by EQ1-
Gal4.
"The egg collection was done at two temperatures, 29uC and 32uC, and
expressions were driven by GR1-Gal4.
¥Two copies of transgene driven by hsGal4 were induced at 37uC for 1 hour,
and then eggs were collected at 25uC.
doi:10.1371/journal.pone.0017097.t003
Figure 5. Expression of D-CblL and RING-SH2
Drk promotes the lysosomal sorting of the Grk-receptor complex. (A–F) Some HRP signals
were colocalized with Rab5-GFP signals in wild-type follicle cells (A, A9 and arrow in B), and more colocalized signals of HRP and Rab5 were detected
in follicle cells expressing RING-SH2
Drk (C, C9 and arrowhead in D), and in cells expressing D-CblL (E, E9 and arrowhead in F). (G–L) Similarly,
significantly more colocalized signals were detected in cells expressing RING-SH2
Drk (I, I9 and arrowhead J) and D-CblL (K, K9 and arrowhead in L) than
that detected in wild-type follicle cells (G, G9 and arrow in H). (M–R) The colocalization signal of HRP and Hrs were shown in the wild-type (M, M9 and
arrow in N), or in cells expressing RING-SH2
Drk (O, O9 and arrowhead in P), and in cells expressing D-CblL (Q, Q9 and arrowhead in R).
doi:10.1371/journal.pone.0017097.g005
Figure 6. The amount of Drk in the EGFR complex. The EGFR
complex were immunoprecipitated by mouse monoclonal anti-EGFR
anti-bodies from ovariant lysates extracted from wild-type females or
females expressing D-CblL, or RING-SH2
Drk in their follicle cells. The
immunoprecipitate was separated by SDS-PAGE, and analyzed by rabbit
polyclonal anti-EGFR (upper panel) or anti-Drk antibodies (lower panel).
The EGFR signal appeared near 170kD (arrowhead in upper panel), and
the Drk signal was near 24kD (arrowhead in lower panel).
doi:10.1371/journal.pone.0017097.g006
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To generate Flag-D-CblL, the D-CblL 328-3533 cDNA
fragment was cloned into pUAST-Flag vector with BagII/KpnI
sites. D-CblL-D70Z was generated by site-directed mutagenesis,
which was designed according to the previously reported method
[20]. To generate the D-CblL-mPR
Drk mutant, we replaced the
Pro
475 and Pro
479 with Ala using site-directed mutagenesis. The
primers used include: Cbl-mut-2270-F 59-gtggtggctgctcccctgcc-
agcccgaaagtcctcacc-39 and Cbl-mut-2270-R 59-ggtgaggactttcgggc
tggcaggggagcagccaccac-3. To generate pUAST-Flag-RING, the
RING finger domain of D-CblL was amplified by PCR using the
following primers: RING-F-KpnI 59-aaggtaccggaccac ataaccgt-
tacccaagag-39 and RING-R-EcoRI 59-aagaattctcagtgtcgtcttcttcc-
39. The RING fragment was cloned into pUAST-Flag using KpnI
and EcoRI sties and was in-frame fused to 39 of the Flag-tag. To
generate pUAST-Flag-RING-SH2
Drk, the SH2 domain of Drk
(amino acid 53 to 160) was amplified from the Drosophila ovarian
cDNA library by PCR using the following primers: SH2-F-RI 59-
aagaattcaatagaaatgaagaatcacgactggtat-39 and SH2-R-XbaI 59-
aatctagacagcgcctg cacgag-39. The SH2
Drk fragment was cloned
into pUAST-Flag-RING using EcoRI and XbaI sties and was in-
frame fused to 39 of the RING finger domain. To generate the
pUAST-Flag-RING-PR, the following two poly-nucleotides PR-F
59-aattcacctcccctgccaccccgat-39 and PR-R 59-ctagatcggggtgg-
caggggaggtg-39 were synthesized in vitro, and they were ligated
to the pUAST-Flag-RING. Therefore, the PR motif is in-frame
fused with the RING domain.
Antibodies
The antibodies used for immunocytochemistry were the mouse
monoclonal anti-Gurken antibody 1D12 [60]; the goat anti-HRP
antibody (Jackson ImmunoResearch, 1:250 dilution); the mouse
anti-Flag (Sigma, 1:250 dilution); the guinea pig anti-FL-Hrs [61];
the Alexa Fluor 499 or 546 goat anti-mouse antibody (Molecular
Probes); the Alexa Fluor 488 or 546 rabbit anti-goat antibody
(Molecular Probes); the TRITC-conjugated donkey anti-mouse
antibody (Jackson ImmunoResearch); and the FITC-conjugated
donkey anti-guinea pig antibody (Upstate). The following
antibodies were used for immunoblotting: mouse anti-D-CblL
8C4 ascites [30], mouse anti-D-Cbl 10F1 ascites [30], mouse anti-
Flag (sigma, 1:500 dilution), rabbit anti-Drk [39], mouse anti-
tubulin (Sigma, 1:3000 dilution).
Immunoprecipitation
The 70 pairs of ovaries were dissected and homogenized with
400 ml lysis buffer (50 mM HEPES, 50 mM NaCl, 10% glycerol,
1% Triton-X, 1 mM EGTA, 1 mM EDTA, 1 mM NaVO3,
1 mM DTT, 10 mM NaF, 10 mM N-ethylmleimide, 0.5%
sodium deoxycholate). The lysates were sonicated and separated
the supernatants by centrifugation at 8000 g for 10 minutes at
4uC. The supernatants were incubated with anti-D-Cbl antibodies
rE6 (1:100) or mouse anti-D-Egfr (1:50 Sigma) for 1.5 hours at
4uC. Then protein A sepharose beads (for rabbits anti-body) or
protein G sepharose beads (for mouse anti-body) were added to
bring down the immunoprecipitates for 2 hours at 4uC. Pellets
were dissolved in 30 ml 2x sample buffer, boiled for 10 minutes.
The samples 10 ml of immunoprecipitates or 30 ml of total lysate
were separated by SDS-PAGE and detected with anti-Drk [39],
8C4 [30], rabbit anti-EGFR [29] antibodies.
Yeast two-hybrid analyses
The full-length Drk was amplified by PCR from the Drosophila
ovarian cDNA library and cloned into the yeast expression
plasmid pGBDT7 (Clontech) to fuse with the DNA-binding
domain of GAL4 protein. The pGBKT7 vector was the negative
control bait. The proline-rich domain of D-CblL was amplified by
PCR and cloned into the yeast expression plasmid pGADT7 to
fuse with the activation domain of GAL4 protein. The bait vector
carrying the TRP1 gene and the prey vector carrying the LEU2
gene were for auxotrophic selection. The pCL1 plasmid carrying
full length GAL4 protein was used as a positive control. The
pGBDT7-Drk was co-transformed into an YH109 yeast strain
(Clontech) either with pGADT7-mPR, or pGADT7-wild-type-PR
or pGADT7 vector, and the transformants were grown on leucine-
tryptophan double selective plates.
Supporting Information
Figure S1 The expression levels of transgenes. (A) To
compare the expression levels between D-CblL and D-CblL-mPR
transgenic lines, UAS-D-cblL (A10 and A12) and UAS-D-cblL-mPR
mutants (AE and GB) were expressed in follicle cells driven by
EQ1-Gal4 at 25uC. The endogenous D-CblL level was detected in
OreR ovary extract. LE indicated long exposure, and SE indicated
short exposure. (B) To compare the expression level of each hs83-
D-cblL transgenic line, the protein samples were extracted from
ovaries carrying the hs83-D-CblL or hs83-D-CblL-mPR mutant
gene. The D-CblL and D-CblL-mPR were detected by a mouse
monoclonal anti-body (8C4). (C) To compare the expression level
of each Flag-D-CblL and Flag-RING-SH2
Drk line, the full-length
D-CblL and chimeras’ expression levels were analyzed by the anti-




compare the expression level of RING, RING-PR and RING-
SH2
Drk transgenic lines, the RING, RING-PR or RING-SH2
Drk
was expressed by GR1-Gal4 at 29uC (left panel). We expressed two
copies of RING or RING-PR either by GR1-Gal4 at 32uCo ra
stronger driver, hsGal4,a t3 7 uC (right panel). The ovarian protein
extracts were separated by SDS-PAGE and analyzed by anti-Flag
anti-body. The number indicated expression level of each line, and
the tubulin served as a loading control. Flag-RING is about 13 kD.
Table 4. D-CblL, RING-SH2
Drk and RING-PR suppresses l-top
effects.




V2* V1* Wt* WtD* D1/D2* N
l-top
38B; LacZ 005 2 3 9 9 / 0 2 7 3
D-CblL-A12 86 14 0 0 0/0 228
l-top
38B; D-CblL-A12 9 3 45 61 0 / 0 1 6 5
RING-SH2
Drk 41 44 15 0 0/0 228
l-top
38B; RING-SH2
Drk-2 009 5 5 0 / 0 2 1 9
l-top




0061 9 9 / 6 62 2 7
*The eggshell pattern of Wt, V1, V2 and V3 were the same as that described in
Table1. WtD indicated extra dorsal appendage appeared in the dorsa-lateral
region; D1 indicated two dorsal appendages appeared in lateral region, and
the dorsal midline area was expanded. D2 indicated the dorsalized eggshell
with dorsal appendage around anterior of egg.
"The egg collection was done at 29uC, and expressions were driven by EQ1-
Gal4.
doi:10.1371/journal.pone.0017097.t004
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Figure S2 Drk interacts with the PR motif of D-CblL. (A)
The interaction between Drk and D-CblL was analyzed by a
yeast-two hybrid system. Yeasts are co-transformed with
pGFBKT7-Drk-FL and pCL1 (as a positive control), pGADT7
vector (as a negative control), wild-type or mPR proline-rich
domain. (B) On the G2 selection plate, the duplicated experiments
show the successful transformation of each line. (C) On the G3
selection plate, yeast containing the PR mutant or the pGADT7
vector could not grow, whereas yeast containing the wild-type or
pCL1 plasmid could grow.
(TIF)
Table S1 Over-expression of D-CblL has little genetic interac-
tion with D-eps15 and D-endophilin B.
(DOC)




Table S3 D-CblL-mPR partially suppresses l-top effects.
(DOC)
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